Advertisement

Netherlands Heart Journal

, Volume 21, Issue 4, pp 189–190 | Cite as

Phantom shocks: innocent bystander or complication of implantable cardioverter defibrillator therapy?

  • A. H. MaassEmail author
Editorial Comment
  • 327 Downloads

Notes

Funding

None.

Conflict of interest

A. H. M. has received lecture fees from Medtronic, Biotronik, Boston Scientific, St. Jude Medical, and Sorin.

References

  1. 1.
    McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRefGoogle Scholar
  2. 2.
    van Veldhuisen DJ, Maass AH, Priori SG, et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail. 2009;11:1143–51.CrossRefGoogle Scholar
  3. 3.
    Smith T, van Dessel PF, Theuns DA, et al. Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J. 2011;19:405–11.CrossRefGoogle Scholar
  4. 4.
    Pedersen SS, Van Den Broek KC, Van Den Berg M, et al. Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: is there more to it than meets the eye? Pacing Clin Electrophysiol. 2010;33:1430–6.CrossRefGoogle Scholar
  5. 5.
    Kraaier K, Strarrenburg AH, Verheggen RM, et al. Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients. Neth Heart J. 2012. doi: 10.1007/s12471-012-0345-z. Epub ahead of print.CrossRefGoogle Scholar
  6. 6.
    Buck S, Rienstra M, Maass AH, et al. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Europace. 2008;10:558–65.CrossRefGoogle Scholar
  7. 7.
    Jacob S, Panaich SS, Zalawadiya SK, et al. Phantom shocks unmasked: clinical data and proposed mechanism of memory reactivation of past traumatic shocks in patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2012;34:205–13.CrossRefGoogle Scholar
  8. 8.
    de Cock CC, Elders J, van Hemel NM, et al. Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands: an expert consensus report of the Netherlands Society of Cardiology. Neth Heart J. 2012;20:53–65.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2013

Authors and Affiliations

  1. 1.Department of Cardiology, ThoraxcenterUniversity of Groningen, University Medical Center GroningenGroningenthe Netherlands

Personalised recommendations